A.R.T. Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-10,000
| Closed | -$274K | – | 1771 |
|
|
2018
Q2 | $274K | Sell |
10,000
-55,600
| -85% | -$1.52M | 0.01% | 1140 |
|
|
2018
Q1 | $2.02M | Buy |
65,600
+3,500
| +6% | +$108K | 0.08% | 380 |
|
|
2017
Q4 | $2.22M | Buy |
62,100
+39,200
| +171% | +$1.4M | 0.1% | 337 |
|
|
2017
Q3 | $630K | Buy |
22,900
+11,200
| +96% | +$308K | 0.03% | 735 |
|
|
2017
Q2 | $308K | Buy |
+11,700
| New | +$308K | 0.02% | 995 |
|
|
2015
Q3 | – | Sell |
-16,460
| Closed | -$526K | – | 1644 |
|
|
2015
Q2 | $526K | Buy |
+16,460
| New | +$526K | 0.02% | 976 |
|